معنی Most applications in biomedical diagnosis are based on immunoassays, often with detection by time-resolved luminescence. The most common approach makes use of antibodies labeled with luminescent Ln(III) (usually Eu3þ) complexes. In the first developed process (heterogeneous immunoassay, Figure 13.13a) [85], the labeled antibody interacts with the immobilized analyte and, after washing, the pH is lowered and the Eu3þ is released and quantified by spectrofluorimetry after complexation with a suitable ligand., معنی Mخسف شححکهرشفهخئس هئ دهخوثیهرشک یهشلئخسهس شقث دشسثی خئ هووعئخشسسشغسپ خبفثئ صهفات یثفثرفهخئ دغ فهوث-قثسخکذثی کعوهئثسرثئرثپ Tاتث وخسف رخووخئ شححقخشرات وشمثس عسث خب شئفهدخیهثس کشدثکثی صهفات کعوهئثسرثئف Lئ(III) (عسعشککغ Eع3þ) رخوحکثزثسپ Iئ فاتث بهقسف یثذثکخحثی حقخرثسس (اتثفثقخلثئثخعس هووعئخشسسشغپ Fهلعقث 13پ13ش) ج85چپ فاتث کشدثکثی شئفهدخیغ هئفثقشرفس صهفات فاتث هووخدهکهطثی شئشکغفث شئیپ شبفثق صشساتهئلپ فاتث حH هس کخصثقثی شئی فاتث Eع3þ هس قثکثشسثی شئی ضعشئفهبهثی دغ سحثرفقخبکعخقهوثفقغ شبفثق رخوحکثزشفهخئ صهفات ش سعهفشدکث کهلشئیپ, معنی Most applications in biomedical diagnosis are based on immunoassays, often with detection by time-resolved luminescence, The most common approach makes use of antibodies labeled with luminescent Ln(III) (usually Eu3þ) complexes, In the first developed process (heterogeneous immunoassay, Figure 13,13a) [85], the labeled antibody interacts with the immobilized analyte and, after washing, the pH is lowered and the Eu3þ is released and quantified by spectrofluorimetry after complexation with a suitable ligand,, معنی اصطلاح Most applications in biomedical diagnosis are based on immunoassays, often with detection by time-resolved luminescence. The most common approach makes use of antibodies labeled with luminescent Ln(III) (usually Eu3þ) complexes. In the first developed process (heterogeneous immunoassay, Figure 13.13a) [85], the labeled antibody interacts with the immobilized analyte and, after washing, the pH is lowered and the Eu3þ is released and quantified by spectrofluorimetry after complexation with a suitable ligand., معادل Most applications in biomedical diagnosis are based on immunoassays, often with detection by time-resolved luminescence. The most common approach makes use of antibodies labeled with luminescent Ln(III) (usually Eu3þ) complexes. In the first developed process (heterogeneous immunoassay, Figure 13.13a) [85], the labeled antibody interacts with the immobilized analyte and, after washing, the pH is lowered and the Eu3þ is released and quantified by spectrofluorimetry after complexation with a suitable ligand., Most applications in biomedical diagnosis are based on immunoassays, often with detection by time-resolved luminescence. The most common approach makes use of antibodies labeled with luminescent Ln(III) (usually Eu3þ) complexes. In the first developed process (heterogeneous immunoassay, Figure 13.13a) [85], the labeled antibody interacts with the immobilized analyte and, after washing, the pH is lowered and the Eu3þ is released and quantified by spectrofluorimetry after complexation with a suitable ligand. چی میشه؟, Most applications in biomedical diagnosis are based on immunoassays, often with detection by time-resolved luminescence. The most common approach makes use of antibodies labeled with luminescent Ln(III) (usually Eu3þ) complexes. In the first developed process (heterogeneous immunoassay, Figure 13.13a) [85], the labeled antibody interacts with the immobilized analyte and, after washing, the pH is lowered and the Eu3þ is released and quantified by spectrofluorimetry after complexation with a suitable ligand. یعنی چی؟, Most applications in biomedical diagnosis are based on immunoassays, often with detection by time-resolved luminescence. The most common approach makes use of antibodies labeled with luminescent Ln(III) (usually Eu3þ) complexes. In the first developed process (heterogeneous immunoassay, Figure 13.13a) [85], the labeled antibody interacts with the immobilized analyte and, after washing, the pH is lowered and the Eu3þ is released and quantified by spectrofluorimetry after complexation with a suitable ligand. synonym, Most applications in biomedical diagnosis are based on immunoassays, often with detection by time-resolved luminescence. The most common approach makes use of antibodies labeled with luminescent Ln(III) (usually Eu3þ) complexes. In the first developed process (heterogeneous immunoassay, Figure 13.13a) [85], the labeled antibody interacts with the immobilized analyte and, after washing, the pH is lowered and the Eu3þ is released and quantified by spectrofluorimetry after complexation with a suitable ligand. definition,